Sanofi Share News (SAN.PA)
SAN.PA Share
SAN.PA Share
SAN.PA Share
SAN.PA Share
SAN.PA Share
SAN.PA Live
SAN.PA
Last checked at -
Wed, 07th Dec 2022 08:09
PARIS, Dec 7 (Reuters) - Sanofi shares rose by around 8% in early Paris stockmarket trading on Wednesday after the company avoided thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.
GSK Plc, Pfizer Inc, and unlisted Boehringer Ingelheim were also among the companies benefitting from the court ruling. (Reporting by Tassilo Hummel; Editing by Sudip Kar-Gupta)
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at
Read moreWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at
Read moreSTOXX 600 falls for the fourth straight day
*Read moreThousands of Zantac lawsuits dismissed on Tuesday
*Read moreDec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.
Read moreDec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday defeated thousands of lawsuits in U.S. federal court claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.
Read moreSanofi slips amid Horizon deal talks
*Read morePARIS, Dec 2 (Reuters) - French drugmaker Sanofi said on Friday that if it decides to bid for biotech company Horizon Therapeutics Plc, it would do so in cash.
Read more
Last checked at